(MedPage Today) — Baerveldt implant does have greater risk for hypotony
Researchers find ranibizumab drug as effective alternative to laser therapy for treating diabetic retinopathy
In a randomized clinical trial of more than 300 participants, researchers from Johns Hopkins and elsewhere have found that ranibizumab — a drug most commonly used to treat retinal swelling in people with diabetes — is an effective alternative to laser therapy for treating the most severe, potentially blinding form of diabetic retinal disease. Results of the government-sponsored study also show that the drug therapy carries fewer side effects than the currently used laser treatment.
Ophthalmology’s data science initiative yields important clinical post-surgery insights
American Academy of Ophthalmology’s IRIS Registry reveals new information on eye inflammation rates following cataract surgery and anti-VEGF injections.
New tech helps handlers monitor health, well-being of guide dogs
Researchers at North Carolina State University have developed a device that allows people who are blind to monitor their guide dogs, in order to keep tabs on the health and well-being of their canine…
Ophthotech Announces that Genentech, a Roche Wholly-Owned Subsidiary, Elects to Exercise Its Right to Opt-in to the Novartis Portion of the Ophthotech / Novartis Ex-US Agreement for Fovista® to Treat Wet Age-Related Macular Degeneration
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Genentech has elected to exercise its option to participate in the financial arrangements relating to Novartis’ rights under the Ophthotech/Novartis ex-US agreement.
Nearsightedness progression in children slowed down by medicated eye drops
Researchers present findings on five-year clinical trial of low-dose atropine for myopia at AAO 2015, the American Academy of Ophthalmology’s annual meeting.